samir awad

Dr. samir awad


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2010 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
Ameen A. Abu-HashemAmeen A. Abu-Hashem
Ameen A. Abu-Hashem
SAsamir awad
samir awad
FBFarid Badria
Farid Badria
2-Amino-5-acetyl-4-methyl-thiophene-3-carboxylic acid ethyl ester (1) and 5-acetyl-2-amino-4-methylthiophene-3-carbohydrazide (2) were synthesized and used as starting materials for the synthesis of new series of 1-(5-amino-4-(3,5-dimethyl-1H-pyrazole-1-carbonyl)-3-methylthiophen-2-yl) ethanone (3a), 1-(5-amino-4-(4-chloro-3,5-dimethyl-1H-pyrazole-1-carbonyl)-3-methylthiophen-2-yl) ethanone (3b), 1-(4-methyl-2-amino-5-acetylthiophene-3-carbonyl)pyrazolidine-3,5-dione (4), (Z)-N'-(4-methyl-2-amino-5-acetylthiophene-3-carbonyl) formohydrazonic acid (5a), (Z)-ethyl-N'-4-methyl-2-amino-5-acetylthiophene-3-carbonylformo hydrazonate (5b), 6-acetyl-3-amino-2,5-dimethylthieno[2,3-d]pyrimidin-4(3H)-one (8), 5-methyl-3-amino-2-mercapto-6-acetylthieno [2,3-d]pyrimidin-4(3H)-one (10) and 5-methyl-6-acetyl-2-thioxo-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-one (12) as potential antioxidant and antitumor agents. Pharmacological tests showed that compounds 6a, 6b, 8, 10 and 12 exhibited significant antitumor and antioxidant activity.

11 March 2011 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
Ameen A. Abu-HashemAmeen A. Abu-Hashem
Ameen A. Abu-Hashem
KAKhadiga M. Abu-Zied
Khadiga M. Abu-Zied
SAsamir awad
samir awad

1 November 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SAsamir awad
samir awad
RSR.H. Swellem
R.H. Swellem
SASh.M. Abu-Bakr
Sh.M. Abu-Bakr
EEE.M. El-Telbani
E.M. El-Telbani

9 June 2015 in Zeitschrift für Naturforschung B
Verified
Journal Article
Closed access
AFAwatef A. Farag
Awatef A. Farag
SAsamir awad
samir awad
SASamir Abbas
Samir Abbas
SASafaa N. Abd-Alrahman
Safaa N. Abd-Alrahman
AAAbeer A. Atrees
Abeer A. Atrees
YAYousry A. Ammar
Yousry A. Ammar

Verified
Journal Article
Open access
PDF file
SFSamar S. Fatahala
Samar S. Fatahala
AIAmira Ibrahim
Amira Ibrahim
SMShahenda mahgoub
Shahenda mahgoub
HTHeba Taha
Heba Taha
MEMohamed-I Kotb El-Sayed
Mohamed-I Kotb El-Sayed
RERania El-Hameed
Rania El-Hameed
In an effort to discover potent anticancer agents, 2-thiouracil-5-sulfonamides derivatives were designed and synthesized. The cytotoxic activity of all synthesized compounds was investigated against four human cancer cell lines viz A-2780 (ovarian), HT-29 (colon), MCF-7 (breast), and HepG2 (liver). Compounds 6b,d–g, and 7b showed promising anticancer activity and significant inhibition of CDK2A. Moreover, they were all safe when tested on WI38 normal cells with high selectivity index for cancer cells. Flow cytometric analysis for the most active compound 6e displayed induction of cell growth arrest at G1/S phase (A-2780 cells), S phase (HT-29 and MCF-7 cells), and G2/M phase (HepG2 cells) and stimulated the apoptotic death of all cancer cells. Moreover, 6e was able to cause cycle arrest indirectly through enhanced expression of cell cycle inhibitors p21 and p27. Finally, molecular docking of compound 6e endorsed its proper binding to CDK2A, which clarifies its potent anticancer activity.